Information for Victims in the New England Compounding Center (NECC) Case
Between approximately May and September, 2012, the New England Compounding Center (NECC) distributed three lots of preservative-free methylprednisolone acetate (MPA) to approximately 76 out-patient surgery centers in 20 different states. The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA), continues to investigate and monitor a multistate outbreak of fungal meningitis and other infections among patients who received contaminated preservative-free MPA steroid injections from these three lots.
Both the CDC and FDA have dedicated websites that provide updated information about the outbreak and about NECC:
- http://www.cdc.gov/HAI/outbreaks/meningitis.html
- http://www.fda.gov/Drugs/DrugSafety/FungalMeningitis/default.htm
The FBI, the FDA’s Office of Criminal Investigations, and other federal agencies opened a criminal investigation of NECC in October 2012. The FBI is concerned about the devastating impact the outbreak has had on victims and their families. Providing information and assistance to victims is an important part of our work.
There is a newly established NECC Victim Compensation Program. The new program is funded by the U.S. Department of Justice, Office for Victims of Crime, and is being administered by the Massachusetts Office of the Attorney General. The application form and related information is available on the state website www.mass.gov/ago/neccassistance under “How can I apply to receive compensation for my expenses as a result of this crime?”
In addition to the information provided by the CDC, FDA, and Massachusetts Attorney General’s Office, the following are resources that may be of help to you:
